ERX Trademark
Serial Number: 79317871
ERX is a trademark filed by
Saluda Medical Pty Ltd
on July 16, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific).
The application is currently no longer active.
Trademark Classes
9
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
10
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
42
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Terry Trade Mark Attorneys
PO BOX 613
WINDSOR NSW 2756
AUSTRALIA
Trademark Details
Filing Date
July 16, 2021
Registration Date
Not Registered
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 3, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 6, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 4, 2023 FICR
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 14, 2023 DENA
DEATH OF INTERNATIONAL REGISTRATION
Mar 13, 2023 DETH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 6, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 18, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 18, 2023 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 7, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 4, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 4, 2022 ABN2
REFUSAL PROCESSED BY IB
May 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2022 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 14, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 13, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 20, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 12, 2021 REPR
